ce-spotlight

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.

---------------------------------

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------

banner rdc


	This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline), track and print your professional transcript and more…


	Pharmacist e-Link CE Spotlight

Improving Asthma Patient Outcomes with Community Pharmacist Interventions
This activity discussed up to date treatment guidelines for managing your Asthma patients for better disease control and healthcare outcomes.
Commercial support provided by AstraZeneca.

thumbnail

Counterfeit Drugs: How Pharmacists Can Help Protect the Medication Supply
This program will help pharmacists initiate strategies to prevent counterfeit drugs from reaching the patient.
Commercial support provided Ortho-McNeil.

Other Featured CE

thumbnail

Update on the Drug Therapy Management of Allergic Rhinitis
This activity provides the pharmacist with patient identification, treatment guidelines and valuable counseling tips for the patient with allergic rhinitis.
Commercial support provided by GlaxoSmithKline and Sanofi Aventis.

thumbnail

Taking Action Against Skin Reactions
Community pharmacists are consulted by the public for a variety of self care treatments due to their accessibility. It is important that the pharmacist know which self care treatment is appropriate and most importantly, when the patient should be referred to a primary health care provider.
No commercial supporter.

	Treat to Target/Target to Treat: Role of Early Therapy in the Management of Type 2 Diabetes The goal of this web-based, interactive multimedia activity is to disseminate and reinforce clinical recommendations for the management of Type 2 Diabetes through a discussion of the rationale for supporting early, aggressive treatment to improve patient outcomes. Commercial support provided by Merck & Co., Inc.

	Please click here to forward this newsletter to a friend